Religare Enterprises reported a standalone net loss of ₹337.99 crore for FY26, widening from ₹375.43 crore in FY25, with a Q4 standalone loss of ₹123.65 crore.
The board approved a demerger scheme to transfer its financial services business to subsidiary Religare Finvest Limited, pending regulatory and NCLT approvals.
The company completed a preferential warrant issue, raising ₹41 crore, and made a significant ₹256.10 crore right issue investment in subsidiary Care Health Insurance.
Auditors issued an unmodified opinion but emphasized ongoing income tax litigations with demands totaling ₹10.85 crore as a matter of emphasis.